Advertisement

Topics

Agile Therapeutics, Inc Company Profile

16:15 EDT 23rd September 2017 | BioPortfolio

Agile Therapeutics, Inc. is a pharmaceutical product development company founded in 1997 based on developing novel pharmaceutical products utilizing its proprietary transdermal drug delivery technology. The company's lead product is a second generation contraceptive patch, currently in phase II clinical testing. Agile's technology is making the trusted oral contraceptive hormones, levonorgestrel and ethinyl estradiol, available for the first time in a small, visually appealing 7-day patch. The market demand for transdermal contraception is strong, and this new product will add an attractive choice for women who wish to utilize this method of contraception but prefer a small patch with the same hormone combination found in popular oral contraceptives. The company is backed by a solid management team and committed investors.

Location

One Tower Bridge, 100 Front Street
West Conshohocken
Pennsylvania
19428
United States of America

Contact

Phone: 610 940 0300
Fax: 610 940 .0301
Email: daria@whiteseahorse.com


News Articles [1551 Associated News Articles listed on BioPortfolio]

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla

PRINCETON, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women's healthcare company, today announced that the U.S. Food and Drug Administration (FD...

Agile Therapeutics Resubmits New Drug Application for its Transdermal Contraceptive Patch, Twirla

PRINCETON, N.J., June 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (F...

Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla

PRINCETON, N.J., May 06, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced the presentation of additional results of its Phase 3 SECURE tr...

Agile Therapeutics nets $18.8mm in FOPO

Women's health company Agile Therapeutics Inc. (transdermal patch contraceptives) netted $18.8mm through the public offering of 5.33mm shares at $3.75. The company will use the proceeds to pursue regu...

Agile Therapeutics: Is This ~$3.50 'Busted IPO' Worthy Of Investment Consideration?

Agile Therapeutics: No Reason For The FDA To Approve Another Inferior Patch

Agile Therapeutics Reports First Quarter 2017 Financial Results

PRINCETON, N.J., May 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company today reported financial results for the three months ended March 31, 2017, ...

Agile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference

PRINCETON, N.J., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company, announced today that Al Altomari, Chairman and CEO...

PubMed Articles [565 Associated PubMed Articles listed on BioPortfolio]

Instructed subsets or agile swarms: how T-helper cells may adaptively counter uncertainty with variability and plasticity.

Over recent years, extensive phenotypic variability and plasticity have been revealed among the T-helper cells of the mammalian adaptive immune system, even within clonal lineages of identical antigen...

Meat quality attributes of Agile Wallabies.

Meat quality traits of Agile Wallaby (Macropus agilis) M. longissimus (loin) and M. semimembranosus (topside) were investigated. Both muscles exhibited a relatively high pH (>5.7) and dark colour (L*-...

Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.

Response to Aslankurt et al. re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model".

Is the Eye an Extension of the Brain in Central Nervous System Disease?

Clinical Trials [117 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1182 Associated Companies listed on BioPortfolio]

Agile Therapeutics, Inc

Agile Therapeutics, Inc. is a pharmaceutical product development company founded in 1997 based on developing novel pharmaceutical products utilizing its proprietary transdermal drug delivery technolog...

Agile Therapeutics, Inc.

Agile Therapeutics is a pharmaceutical development company specializing in women’s healthcare products, with an initial focus on developing safer, more convenient methods of ...

Agile Software Corporation

Agile Software Corporation (NASDAQ: AGIL) helps companies drive profits, accelerate innovation, reduce costs, and ensure regulatory compliance throughout the product lifecycle. With a broad suite of e...

Point of Care Solutions

Point of Care Solutions, LLC (“POCS”) is an agile medical platform designed to provide small medical practices with the IT tools they need to create a positive patient ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Agile Therapeutics, Inc" on BioPortfolio

We have published hundreds of Agile Therapeutics, Inc news stories on BioPortfolio along with dozens of Agile Therapeutics, Inc Clinical Trials and PubMed Articles about Agile Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Agile Therapeutics, Inc Companies in our database. You can also find out about relevant Agile Therapeutics, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record